Author

J. E. Rodriguez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4 Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Assay:proteomics· 5 Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Assay:bulk RNA-seq· 2 Approach:statistical model· 2 Organism:Arabidopsis· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

A. Vegvari· 5 shared S. Gupta· 4 shared U. Neogi· 4 shared A. Mirazimi· 3 shared E. Saccon· 3 shared F. Mikaeloff· 3 shared B. S. Vinhas· 2 shared R. Benfeitas· 2 shared

Activity by Year

2020-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersMicrobiology

A. Vegvari

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Interspecies isobaric labeling-based quantitative proteomics reveals protein changes in the ovary of Aedes aegypti co-infected with ZIKV and Wolbachia

L. F. C. Ramos, M. Martins, J. E. Rodriguez, G. B. Domont, D. M. P. d. Oliveira, F. C. S. Nogueira, R. Maciel-de-Freitas, M. Junqueira

This study uses quantitative proteomics to analyze protein changes in Ae. aegypti ovaries co-infected with ZIKV and Wolbachia, identifying immune and reproductive pathway alterations.

bioRxiv · Mar 11, 2022 · PreprintBiochemistry

Single Cell Chemical Proteomics (SCCP) Interrogates the Timing and Heterogeneity of Cancer Cell Commitment to Death

A. Vegvari, J. E. Rodriguez, R. Zubarev

This study applies single cell chemical proteomics to analyze the time-dependent and heterogeneous response of cancer cells to anticancer drugs.

bioRxiv · Apr 21, 2021Cancer Biology

Implications of central carbon metabolism in SARS-CoV-2 replication and disease severity

S. Krishnan, H. Nordqvist, A. T. Ambikan, S. Gupta, M. Sperk, S. Svensson-Akusjarvi, F. Mikaeloff, R. Benfeitas, E. Saccon, S. M. Ponnan, J. E. Rodriguez, N. Nikouyan, A. Odeh, G. Ahlen, M. Asghar, , U. Neogi

This study investigates how SARS-CoV-2 affects central carbon metabolism in host cells and links metabolic changes to disease severity.

bioRxiv · Feb 24, 2021Microbiology

Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells

X. Chen, E. Saccon, K. S. Appelberg, F. Mikaeloff, J. E. Rodriguez, B. S. Vinhas, T. Frisan, A. Vegvari, A. Mirazimi, U. Neogi, S. Gupta

This study identifies delayed and dysregulated type-I interferon signaling in SARS-CoV-2 infected Huh7 cells and shows that IFN-I pretreatment reduces susceptibility.

bioRxiv · Feb 4, 2021Microbiology

Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo Hemorrhagic Fever Viruses for novel therapeutic target

U. Neogi, N. Elaldi, S. Appelberg, A. Ambikan, E. Kennedy, S. D. Dowall, B. K. Bagci, S. Gupta, J. E. Rodriguez, S. Svensson-Akusjärvi, V. Monteil, A. Vegvari, R. Benfeitas, A. Banerjea, F. Weber, , A. Mirazimi

This study uses multi-omics approaches to analyze host-viral interactions in CCHFV infection, identifying metabolic reprogramming and interferon-mediated antiviral mechanisms as potential therapeutic targets.

bioRxiv · Dec 10, 2020Microbiology

Tropism of SARS-CoV-2 in commonly used laboratory cell lines and their proteomic landscape during infection

E. Saccon, X. Chen, F. Mikaeloff, J. E. Rodriguez, L. Szekely, B. S. Vinhas, S. Krishnan, S. Byrareddy, T. Frisan, A. Vegvari, A. Mirazimi, U. Neogi, S. Gupta

This study assesses SARS-CoV-2 tropism and proteomic changes in human cell lines, finding cell-type-specific susceptibility and interferon signaling dysregulation.

bioRxiv · Aug 28, 2020Microbiology